Searched for
AFLIBERCEPT BIOSIMILAR INDIA
Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran ShawBiocon is planning a ₹4,500 crore fundraise to increase promoter stake in Biocon Biologics and convert structured venture debt into equity,...15 May, 2025, 12.19 AM IST- How is India transforming the global biopharma landscape?In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...30 Dec, 2024, 11.08 PM IST
- Biocon Biologics to raise debt of Rs 4,500 crore for Viatris PayoutBiocon Biologics plans to raise ₹4,500 crore with HSBC and MUFG's aid for a $175 million Aflibercept option. Previous funding by Kotak and ...12 Jul, 2024, 07.40 AM IST
- 12 stocks that are BofA Securities' top buys from 7 sectors. Do you own them?While BofA remained overweight on select domestic cyclicals such as industrials, financials and automobile stocks, it has marginally trimme...22 Jun, 2022, 04.35 PM IST
- Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar AfliberceptListed pharmaceutical entity Shilpa Medicare on Monday informed the exchanges that its subsidiary Shilpa Biologicals (SBPL) has received a ...25 Apr, 2022, 01.18 PM IST
- Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...01 Mar, 2022, 10.05 AM IST
- Biocon Biologics acquires Viatris' biosimilar business for $3.34 billionBBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded b...28 Feb, 2022, 07.50 AM IST
Load More
